Fortress Biotech, Inc.

  • Home
  • About
    • Overview
    • Business Development
    • Management Team
    • Board of Directors
    • FAQ
  • Programs
    • Pipeline
    • Marketed Products
    • Publications
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • Analyst Coverage
    • SEC Filings
    • Governance
    • Resources
  • Contact
  • Careers
  • FAQ
  • Accessibility Statement

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events

Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

Oct 09, 2024

Journey Medical Corporation to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Oct 03, 2024

Fortress Biotech to Participate in October 2024 Investor Conferences

Sep 26, 2024

Fortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private Placements

Sep 20, 2024

Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024

Sep 16, 2024

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference

Sep 09, 2024

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 04, 2024

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 04, 2024

Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Sep 04, 2024

Avenue Therapeutics to Participate in Upcoming Investor Conferences

Sep 03, 2024
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...71
    Next

    Fortress Biotech programs include product candidates in development at Fortress, its majority-owned and majority-controlled partner companies and entities in which it holds minority ownership positions.

    © 2025 Fortress Biotech, Inc. All Rights Reserved.
    Facebook Twitter Linkedin
    Accessibility Statement Privacy Policy Disclaimer Sitemap